Netherlands

Resolution L3 – Ensuring access to drug treatment, education, aftercare, rehabilitation and social reintegration services for marginalized populations(cont.)

Chair: I would like to start with a personal remark. I had some requests of delegations, and distinguished colleagues from Australia, France, and Turkey… I would like to explain that here, it’s not too easy to work through mutual rule, as it is for you. Regarding time zones – it’s the life is for everybody: …

Read more

Resolution L3 – Ensuring access to drug treatment, education, after-care, rehabilitation, and social reintegration services, for people within marginalized populations (cont.)

Chair: Welcome back to the Committee of the Whole. I hope you all had a good night and everybody is ready, in good spirits, and in constructive spirits. Last night, resolution six by Nigeria was agreed in the committee and submitted to the Plenary. As soon as the English version is available, it will be posted on …

Read more

Plenary – Agenda item 3: General Debate (continued)

Chair: Because of technical difficulties, we will not start with the Global Fund, so we will start with speakers left from yesterday. Please, limit your statements to 3 minutes. Kazakhstan: CND offers a unique platform to share information and strengthen cooperation. Weve all seen negative trends. This requires continued improvement and focused efforts. Important to …

Read more

Side event: Drug crypto markets beyond 2020: Policy, enforcement, harm, and resilience

Organized by the Government of the Netherlands, Asociación Bienestar y Desarollo (Energy Control), the Global Drug Policy Observatory and the International Drug Policy Consortium Anke ter Hoeve, Netherlands: The Netherlands is a staunch supporter of evidence based drug policymaking. We had a side event on the matter and submitted a resolution which commanded great support. …

Read more

Committee of the Whole (Thursday morning) L4. Promoting awareness-raising, education and training as part of a comprehensive approach to ensuring access to and the availability of controlled substances for medical and scientific purposes and improving their rational use

EC77/2020/L4   Belgium:There are some paras where the wording is ‘non-stigma’. A couple of paras have been agreed in informals pending on the solution of non-stigmatisation. Chair: Canada was the state proposing language on stigma Canada: If we are going to focus on PPs first we did have discussions during informals. Linking PP that references stigma …

Read more